GI Motility Program News

News Releases

Below are news releases and up-to-date information relating to gastrointestinal health, medical advances, promising research studies and the GI Motility Program at Cedars-Sinai Medical Center.

• Cedars-Sinai physician definitively links irritable bowel syndrome (IBS) and bacteria in gut (May 25, 2012)
• Researchers identify drugs with fewest side effects for treating irritable bowel syndrome (March 26, 2012)
• Cedars-Sinai 12th Annual Educational Meeting in Gastroenterology was held on March 9-10, 2012. Co-directed by Laith H. Jamil, M.D., the latest advances in gastroenterology were presented by a team of national experts, highlighting the multidisciplinary management of GI disorders.
• Targeted Antibiotic Drug Safest Among Recommended Treatments for Irritable Bowel Disease, Study Finds (November 1, 2011)
• Cedars-Sinai Research Deepens Understanding of Most Common Gastrointestinal Disorder in U.S., Linking it to Bacterial Overgrowth, Food Poisoning (May 10, 2011)
• Research Shows Antibiotic Treatment Effective for Most Common Gastrointestinal Disorder in U.S. (January6, 2011)

•  Cedars-Sinai Researchers Find Link Between Methane Production and Obesity (May 5, 2010)

• Study Shows That Targeted Antibiotics Lead to Prolonged Improvement in IBS Symptoms (October 17, 2006)
• Immune Signals Given by Variations of a Single Gene Are Associated with Increased Severity of Crohn's Disease, Particularly in Ashkenazi Jews (May 22, 2006)
• IBS Study Shows that Targeted Antibiotics Lead to Long-Lasting Improvement in Symptoms (November 8, 2005)
• The Center for Digestive Diseases at Cedars-Sinai named 11th in U.S. News and World Report Rankings for Best Hospitals.